Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, American Association of Clinical Endocrinologists
We still need: Larger, long-term studies specifically focusing on psoriasis and PsA patients More data on optimal dosing and treatment duration Better understanding of how these drugs interact with current psoriasis and PsA treatments Empowering Your Psoriasis and PsA Management: Explore GLP-1 Options If you have psoriasis or PsA and struggle with weight management or treatment resistance, GLP-1 receptor agonists offer a new avenue for improving your condition
Change in alcohol consumption following liraglutide initiation: A real life experience
Diarrhea is a side effect of changed digestion, not a measure of results
What medications should people not take with semaglutide
Today, we know that the type of fat you eat matters far more than the amount